Virchows Archiv

, Volume 425, Issue 5, pp 481–489 | Cite as

Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings

  • V. Gorgoulis
  • G. Rassidakis
  • C. Kittas
  • A. Giatromanolaki
  • C. Barbatis
  • A. Karameris
Original Article


In order to evaluate the expression of p53 protein in 28 premalignant and 40 malignant squamous cell proliferations of the larynx and its relationship to tobacco consumption, human papillomavirus infection and differentiation grade of the lesions, p53 expression was examined by means of a microwave post-fixation immunohistochemical method using the PAb 240 and PAb 1801 monoclonal antibodies. HPV infection was assessed by non-isotopic in situ hybridization (NISH) and polymerase chain reaction (PCR). A large proportion of carcinomas (77.5%) and dysplasias (61%) expressed p53. No difference was found between differentiation grades of the lesions regarding p53 detection (P>0.1), but moderate or intense p53 expression was more frequent in the carcinomas (P<0.05). A statistical correlation was found between cigarette consumption and both p53 detection and p53 staining intensity (P<0.05 in each case). HPV study revealed HPV 16 and 18 infection only in carcinomas. The frequency was 28% and the physical state of the virus as demonstrated by NISH was integration into the genome. We observed an inverse relationship between HPV infection and p53 expression (P=0.006). Our findings suggest that p53 overexpression is a common and early event which increases in frequency with progression of laryngeal squamous cell carcinoma. The expression of p53 is influenced by tobacco and high-risk types of HPV.

Key words

p53 Human papillomavirus Polymerase chain reaction In situ hybridization Laryngeal squamous cell carcinoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anwar K, Nakakuki K, Naiki H, Inuzuka M (1993) ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer 53:22–28Google Scholar
  2. 2.
    Anwar K, Nakakuki K, Imai H, Naiki H, Inuzuka M (1993) Over-expression of p53 protein in human laryngeal carcinoma. Int J Cancer 53:952–956Google Scholar
  3. 3.
    Banks L, Matlashewski G, Crawford L (1986) Isolation of human-p53-specific antibodies and their use in studies of human p53 expression. Eur J Biochem 159:529–534Google Scholar
  4. 4.
    Batsakis JG (1979) Tumors of the head and neck: clinical and pathological considerations, 2nd edn. Williams and Wilkins, Baltimore, p 574Google Scholar
  5. 5.
    Borresen AL, Helland A, Nesland J, Holm R, Trope C, Kaern J (1992) Papillomaviruses, p53 and cervical cancer. Lancet 339:1350–1351Google Scholar
  6. 6.
    Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, ZurHausen H (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3:1151–1157Google Scholar
  7. 7.
    Boyle JO, Hakim J, Koch W, Riet P van der, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM, Sidransky D (1993) The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53:4477–4480Google Scholar
  8. 8.
    Brandsma JL, Steinberg BM, Abramson AL, Winkler B (1986) Presence of human papilloma virus type 16 related sequences in verrucous carcinoma of the larynx. Cancer Res 46:2185–2188PubMedGoogle Scholar
  9. 9.
    Braun L, Durst M, Mimuko R, Grupposo P (1990) Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor β. Cancer Res 50:7324–7332Google Scholar
  10. 10.
    Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C, Key G, D'amato L, Sabattini E, Feudale E, Reynolds F, Gerdes J, Rilke F (1993) Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171:83–98Google Scholar
  11. 11.
    Cole ST, Streeck RE (1986) Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol 58:991–995Google Scholar
  12. 12.
    Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO'D (1991) In situ evidence for HPV 16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol 44:406–409Google Scholar
  13. 13.
    Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH (1992) Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 339:1070–1073Google Scholar
  14. 14.
    Dartmann K, Schwarz E, Gissmann L, ZurHausen H (1989) The nucleotide sequence and genome organization of human papillomavirus 11. Virology 151:124–130Google Scholar
  15. 15.
    Deb S, Jackson CT, Subler MA, Martin DW (1992) Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J Virol 66:6164–6170Google Scholar
  16. 16.
    Dekmezian RH, Batsakis JG, Goepfert H (1987) In situ hybridization of papillomavirus DNA in head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 113:819–821Google Scholar
  17. 17.
    Demers GW, Halbert CL, Galloway DA (1994) Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E6 gene. Virology 198:169–174Google Scholar
  18. 18.
    DeVilliers EM (1989) Heterogeneity of the human papillomavirus group. J Virol 63:4898–4903Google Scholar
  19. 19.
    Dolcetti R, Doglioni C, Maestro R, Gasparotto T, Barzan L, Pastore A, Romanelli M, Boiocchi M (1992) p53 overexpression is an early event in the development of human squamous cell carcinoma of the larynx; genetic and prognostic implications. Int J Cancer 52:178–182Google Scholar
  20. 20.
    Edmundson WF (1948) Microscopic grading of cancer and its practical implication. Arch Dermatol Syphilol 57:141–150Google Scholar
  21. 21.
    Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM (1991) Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 64:573–577Google Scholar
  22. 22.
    Fuzita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T (1992) Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52:5223–5328Google Scholar
  23. 23.
    Gannon JV, Greaves R, Iggo R, Lane DP (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 9:1595–1602Google Scholar
  24. 24.
    Gloss B, Bernard HV, Seedorf K, Klock G (1987) The up-stream regulatory region of human papilloma virus 16 contains an E2 protein-independent enhancer with is specific for cervical cells and regulated by glucocorticoid hormones. EMBO J 6:3735–3743Google Scholar
  25. 25.
    Gorgoulis V, Giatromanolaki A, Karameris A, Tsatsanis C, Aninos D, Ozanne B, Velsemes M, Jordanoglou J, Trigidou R, Papastamatiou H, Spandidos DA (1993) Epidermal growth factor receptor expression in squamous cell lung carcinomas: an immunohistochemical and gene analysis in formalin-fixed, paraffin-embedded material. Virchows Arch [A] 423:295–302Google Scholar
  26. 26.
    Hainaut P, Milner J (1992) Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation. EMBO J 11:3513–3520Google Scholar
  27. 27.
    Halevy O, Michalowitz D, Oren M (1990) Different tumor-derived p53 mutants exhibit distinct biological activities. Science 250:113–116Google Scholar
  28. 28.
    Harris AL (1990) Mutant p53 — the commonest genetic abnormally in human cancer; (editorial) J Pathol 162:5–6Google Scholar
  29. 29.
    Harris CC (1993) p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262:1980–1981Google Scholar
  30. 30.
    Hellquist H, Lundgren J, Olofsson J (1982) Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords: a follow-up study. Clin Otolaryngol 7:11–27Google Scholar
  31. 31.
    Herrington CS, Burns J, Graham AK, Bhatt B, McGee JO'D (1989) Interphase cytogenetic using biotin and digoxigenin labelled probes. I. Relative sensitivity of both reporter molecules for the detection of HPV 16 in CaSki cells. J Clin Pathol 42:591–600Google Scholar
  32. 32.
    Hollstein MC, Metcalf RA, Welsh A, Montesano R, Harris CC (1990) Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 887:9958–9961Google Scholar
  33. 33.
    Hollstein MC, Peri L, Mandard AM, Wellsh JA, Montesano R, Metcalf RA, Bak M, Harris CC (1991) Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. CancerRes 51:4102–4106Google Scholar
  34. 34.
    Hong W, Yu-chun L, Xiu-shui K, Gang-zhong L, Jie L, Baoyin L, Li-juan Q, Ke-ring M (1991) Detection of human papillomarivus (HPV) in laryngeal carcinoma tissue. Chin Med J 104:523–525Google Scholar
  35. 35.
    Hoshikawa T, Nakajima T, Uhara H, Gotoh M, Shimosato Y, Tsutsumi K, Ono I, Ebihara S (1990) Detection of human papillomavirus DNA in laryngeal squamous cell carcinomas by polymerase chain reaction. Laryngoscope 100:450–647Google Scholar
  36. 36.
    Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675–679Google Scholar
  37. 37.
    Kahn T, Schwarz E, ZurHausen H (1986) Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma. Int J Cancer 37:61–65Google Scholar
  38. 38.
    Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311PubMedGoogle Scholar
  39. 39.
    Levin AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453–456Google Scholar
  40. 40.
    Lorincz AT, Lancaster WD, Temple GF (1986) Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol 58:225–229Google Scholar
  41. 41.
    Lorincz AT, Quinn AP, Lancaster WD, Temple GP (1987) A new papillomavirus associated with cancer of the uterine cervix. Virology 159:187–190Google Scholar
  42. 42.
    Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L, Grandi E, Boiocchi M (1992) High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 7:1159–1166Google Scholar
  43. 43.
    McCoy DG, Wynder EL (1979) Etiological and preventive implications in alcohol carcinogenesis. Cancer Res 39:2844–2850Google Scholar
  44. 44.
    Mercer WE, Baserga R (1985) Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes. Exp Cell Res 160:31–46Google Scholar
  45. 45.
    Mercer WE, Shields MT, Lin D, Appela E, Ullrich SJ (1991) Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating cell nuclear antigen expression. Proc Natl Acad Sci USA 88:1958–1962Google Scholar
  46. 46.
    Michaels L (1984) Pathology of the larynx, chapter 34. Squamous cell carcinoma: epidemilogy, early lesions, biopsy diagnosis. Springer, Berlin Heidelberg New York, pp 199–204Google Scholar
  47. 47.
    Milner J (1991) A conformational hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer. Proc R Soc Lond [B] 245:139–145Google Scholar
  48. 48.
    Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245Google Scholar
  49. 49.
    Morgan DW, Abdullah V, Quiney R, Myint S (1991) Human papilloma virus and carcinoma of the laryngopharynx. J Laryngol Otol 105:288–290Google Scholar
  50. 50.
    Mounts P, Shah K, Kashima H (1982) Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci USA 79:5425–5429Google Scholar
  51. 51.
    Perez-Ayala M, Ruiz-Cabello F, Esteban F, Concha A, Redondo M, Oliva MR, Cabrera T, Carrido F (1990) Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer 46:8–11Google Scholar
  52. 52.
    Pfister H (1987) Human papillomaviruses and genital cancer. Adv Cancer Res 48:113–117Google Scholar
  53. 53.
    Rodrigues NR, Rowan A, Smith M et al. (1990) p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555–7559Google Scholar
  54. 54.
    Scheffner M, Werness BA, Huibregste SM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by HPV types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136Google Scholar
  55. 55.
    Scheurlen W, Stremlau A, Gissmann L, Hohn D, Zenner H-P, ZurHausen H (1986) Rearranged HPV 16 molecules in an anal and in a laryngeal carcinoma. Int J Cancer 38:671–676Google Scholar
  56. 56.
    Schmidt W, Popham RE (1981) The role of drinking and smoking in mortality from cancer and other causes in male alcoholics. Cancer 47:1030–1041Google Scholar
  57. 57.
    Schneider A, Hotz M, Gissman L (1987) Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 40:198–201Google Scholar
  58. 58.
    Schuller DE, Abou-Issa H, Parrish R (1984) Estrogen and progesterone receptors in head and neck cancer. Arch Otolaryngol 110:725–727Google Scholar
  59. 59.
    Schwarz E, Durst M, Demankowski C et al. (1983) DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J 2:2341–2348Google Scholar
  60. 60.
    Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG (1985) Human papillomavirus type 16 DNA sequence. Virology 145:181–185Google Scholar
  61. 61.
    Suler MA, Martin DW, Deb S (1992) Inhibition of viral and cellular promoters by human wild-type p53. J Virol 66:4757–4762Google Scholar
  62. 62.
    Syrjanen S, Syrajanen K, Mantyjarvi R, et al. (1987) Human papillomavirus DNA in squamous cell carcinomas of larynx demonstrated by in situ hybridization. ORL J Otorhinolaryngol Relat Spec 49:175–186Google Scholar
  63. 63.
    Tsutsumi K, Nakajima T, Gotoh M, et al. (1989) In situ hybridization and immunohistochemical study of human papillomavirus infection in adult laryngeal papillomas. Laryngoscope 99:80–85Google Scholar
  64. 64.
    Tuyns AJ (1991) Alcohol and cancer. An instructive association. Br J Cancer 64:415–416Google Scholar
  65. 65.
    Varley GM, Brammar W, Lane DP, Swallow JE, Dolan C, Walker RA (1991) Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Oncogene 6:413–421Google Scholar
  66. 66.
    Watts S, Brewer EE, Fry TL (1991) HPV DNA in head and neck carcinomas. Oral Surg Oral Med Oral Pathol 71:701–707Google Scholar
  67. 67.
    Wynder EL, Stellman SD (1977) Comparative epidemiology of tobacco-related cancers. Cancer Res 37:4608–4622Google Scholar
  68. 68.
    Wynford-Thomas D (1992) p53 in tumour pathology: can we trust immunochemistry? (editorial) J Pathol 166:329–330Google Scholar
  69. 69.
    Young LS, Bevan IS, Johnson MA, Blomfield PI, Maitland NJ, Woodman CBJ (1989). The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ 298:14–18Google Scholar
  70. 70.
    Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855–865Google Scholar
  71. 71.
    ZurHausen H (1989) Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 49:4677–4681Google Scholar
  72. 72.
    ZurHausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9–13Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • V. Gorgoulis
    • 1
    • 2
    • 4
  • G. Rassidakis
    • 1
  • C. Kittas
    • 1
  • A. Giatromanolaki
    • 2
  • C. Barbatis
    • 2
  • A. Karameris
    • 3
  1. 1.Laboratory of Histology and EmbryologyUniversity of Athens School of MedicineAthensGreece
  2. 2.Department of Pathology“Red Cross” HospitalAthensGreece
  3. 3.Department of Pathology401 General Army HospitalAthensGreece
  4. 4.AthensGreece

Personalised recommendations